This conception has been changing during recent years, since it has been reported that resistance to GIP can be reversed and its effectiveness restored by improving glycemic control [14]
Tirzepatide is a novel dual agonist that targets both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor (13, 14)
Neurotox Res 2001;3:545556.ArticlePubMed 13
First-line neuropathic pain treatment includes duloxetine (60 mg once daily), gabapentin, pregabalin, or amitriptyline, following NICE CG173 guidance
Women can stop having regular periods for a lot of reasons, including diabetes, an eating disorder, excessive exercise, being overweight or underweight, chronic physical or mental stress, and taking certain medications
Multiple oestradiol functions inhibit ferroptosis and acute kidney injury